Alpha 2 agonists _ clonidine vs dexmed ### . Also compare pentazocine -butorphenol, morphine - fentanyl . Short and crisp with mnemonics or flashcards for md anaesthesia exam .

Reading File
Now let me search the library in parallel for all four drug comparisons:
Finding Sources
Finding Sources
Finding Sources
Good results found. Now let me read the key textbook sections for full detail:
Reading File
Reading File
Reading File
Excellent data. Let me get more specifics on dexmedetomidine and fentanyl/morphine pharmacokinetics:
Reading File
Reading File
Reading File
I now have comprehensive data from Barash (Clinical Anesthesia), Morgan & Mikhail, and Lippincott. Let me now compose the full answer.

Alpha-2 Agonists, Opioids & Mixed Agonist-Antagonists: MD Anaesthesia Flashcards


πŸƒ CARD 1: Alpha-2 Agonists at a Glance

Mnemonic: "C is for Clumsy; D is for Dexterous"

Clonidine = older, less selective, oral/transdermal
Dexmedetomidine = newer, more selective, IV infusion only

⚑ CLONIDINE vs DEXMEDETOMIDINE - Master Comparison Table

FeatureClonidineDexmedetomidine
Ξ±2 : Ξ±1 selectivity200 : 11600 : 1 (7x more selective)
TypePartial agonistFull agonist
RoutePO, IV, transdermal, epidural, intrathecalIV infusion only
tΒ½Long (~12-16 hr); renal excretionShort (~2 hr); context-sensitive tΒ½ ~13 min (infusion <8 hr)
Onset (IV)SlowFast (~5-10 min)
Site of actionLocus coeruleus, spinal cord, peripheralLocus coeruleus >> medullary vasomotor centre
Sedation qualityMild-moderateUnique: arousable sedation (mimics natural sleep; responds to voice)
AnalgesiaYes (central + spinal)Yes (but weaker analgesic)
AnxiolysisYesYes
Respiratory depressionMinimal / NoneMinimal / None (KEY advantage of both)
CVS effect↓ HR, ↓ BP (no orthostatic hypotension)Biphasic: initial ↑ BP (peripheral Ξ±2B) β†’ then ↓ BP + ↓ HR
MAC reduction~40-50%~40-90% (dose-dependent)
Anti-shiveringYes (thermoregulation threshold ↓)Yes (lowers thermoregulation threshold)
Delirium preventionYesBetter evidence; reduces ICU delirium vs propofol/benzodiazepines
WithdrawalSevere rebound HTN if abruptly stopped (tachycardia, diaphoresis)Less withdrawal risk
HyperglycaemiaYes (inhibits insulin release)Less prominent
OT-eligible usesPremedication, regional adjuvant, chronic pain, HTNICU sedation, awake fibreoptic, paediatric, OSA patients, TIVA adjuvant
Unique useComplex regional pain syndrome, substance withdrawalFunctional neurosurgery (no EEG suppression); bariatric surgery
Ξ²-blocker cautionDo NOT use alone in withdrawal (unopposed Ξ±1 β†’ worse HTN)N/A

Mnemonic for Dexmed's advantages over Clonidine: "7 FARSIES"

  • 7x more selective
  • Fast acting IV
  • Arousable sedation (cooperative patient)
  • Respiratory drive preserved even at high doses
  • Shorter tΒ½ (titratable)
  • ICU delirium reduction
  • Effective in OSA/bariatric
  • Shivering reduced

πŸƒ CARD 2: Alpha-2 Receptor Locations - Mnemonic "Pre-Post-Periphery"

LocationTypeEffect
Presynaptic CNS (LC)Ξ±2A↓ NE release β†’ sedation, analgesia
Postsynaptic medullaryΞ±2A↓ sympathetic outflow β†’ ↓ BP
Peripheral vascular (Ξ±2B)PostjunctionalInitial vasoconstriction β†’ transient ↑ BP (dexmed > clonidine)
Spinal cord (dorsal horn)Ξ±2A/CAnalgesia (used as epidural adjuvant)


πŸƒ CARD 3: Opioid Receptor Quick Reference

Mnemonic: "MKD" = "My Kidneys Ache Daily"
ReceptorEffectsFull agonists
ΞΌ (mu)Supraspinal analgesia (ΞΌ1), respiratory depression (ΞΌ2), physical dependence, muscle rigidityMorphine, Fentanyl
ΞΊ (kappa)Spinal analgesia, sedation, dysphoria, NO respiratory depressionMorphine, Butorphanol, Nalbuphine
Ξ΄ (delta)Analgesia, behaviouralEnkephalins
Οƒ (sigma)Dysphoria, hallucinations, respiratory stimulationPentazocine, Ketamine

⚑ MORPHINE vs FENTANYL - Master Comparison

FeatureMorphineFentanyl
Chemical classPhenanthrene (natural)Phenylpiperidine (synthetic)
Receptorμ (primary), κ, δμ (primarily, highly selective)
Relative potency1x (reference)~100x more potent
Lipid solubilityLow (hydrophilic)High (lipophilic)
Protein binding~35%~80-85%
Onset (IV)15-30 min1-2 min (fast BBB crossing)
Peak effect60-90 min (hysteresis!)5-10 min
Duration3-4 hr30-40 min (bolus)
Context-sensitive tΒ½Long; accumulates with infusionShort initially, INCREASES rapidly with prolonged infusion
MetabolismHepatic glucuronidation β†’ M6G (active, potent), M3G (hyperexcitatory)Hepatic (CYP3A4); inactive metabolites
Active metaboliteMorphine-6-glucuronide (M6G) - prolongs effect in renal failureNorfentanyl (inactive)
Histamine releaseYES (direct mast cell degranulation)NO (major advantage intraop)
CardiovascularBradycardia, hypotension (+ histamine)Minimal - haemodynamically stable; bradycardia (vagotonic)
Chest wall rigidityLessHIGH dose β†’ "wooden chest" (glottic + truncal)
Neuraxial useExcellent (hydrophilic = wide spread, long duration)Less spread (lipophilic = segmental, faster onset)
Clinical usePostop PCA, chronic pain, neuraxial, palliativeIntraoperative (TIVA), procedural sedation, patches (chronic)
Dose (IV bolus)0.1-0.15 mg/kg; titrate 2 mg q5-10 min in PACU1-3 ΞΌg/kg intraop; give 5-10 min before stimulus
Renal cautionYES - M6G accumulates β†’ prolonged sedation/RDSafer in renal failure

Mnemonic: "MORPHINE = Makes Old Receptors Produce Histamine IN Everyone"

Key = histamine release, active metabolite, hydrophilic, long duration

Mnemonic: "FENTANYL = Fast Entry, No Toxin ANd Yielding Lipophilics"

Key = fast onset, no histamine, no active toxic metabolite, lipophilic, 100x potent

πŸƒ CARD 4: Morphine Unique Points for MCQ

  • Hysteresis: Plasma peak β‰  effect peak; peak effect lags by 1-2 hr after IV dose
  • M6G (morphine-6-glucuronide): More potent than morphine itself; accumulates in renal failure β†’ prolonged respiratory depression
  • M3G (morphine-3-glucuronide): No analgesia; causes hyperalgesia, myoclonus, seizures
  • Histamine: Urticaria, bronchospasm, hypotension - treat with antihistamines
  • Neuraxial: Preservative-free only; intrathecal 0.1-0.3 mg gives 12-24 hr analgesia


⚑ PENTAZOCINE vs BUTORPHANOL - Mixed Agonist-Antagonists

FeaturePentazocineButorphanol
Drug classBenzomorphanMorphinan
ΞΌ receptorAntagonist (weak)Weak antagonist / partial agonist
ΞΊ receptorPartial agonistAgonist (primary action)
Οƒ receptorAgonistMinimal
Ξ΄ receptorMinimalMinimal
Potency vs morphine~1/3 (roughly 0.3x)~3-5x more potent
RoutePO, IM, IVIM, IV, intranasal (unique)
AnalgesiaModerate; ceiling effectGood; ceiling effect
SedationLessMore (ΞΊ-mediated)
Dysphoria/hallucinationsYES - common (Οƒ agonism)Less (weak Οƒ)
CVS effects↑ BP, ↑ HR, ↑ PAP (↑ SVR) - AVOID in MI/CADMild ↑ HR, mild ↑ BP
Respiratory depressionCeiling effect (less than full agonists)Ceiling effect; naloxone reverses
Addiction potentialLower (but NOT zero)Lower than full agonists
Precipitates withdrawalYES in opioid-dependent patientsYES
Special cautionDysphoria may need haloperidol; Talwin NX = pentazocine + naloxone (abuse deterrent oral form)Safe in obstetric analgesia
Use in CAD/MICONTRAINDICATED (raises cardiac workload)Use with caution

Mnemonic: "PENTA = Psycho, Elevates NorTensive Arteries"

(Pentazocine causes dysphoria/hallucinations + raises BP/HR/PAP)

Mnemonic: "BUTO = Better, nasal Use, Twice Or more potent"

(Butorphanol is more potent, available intranasally, fewer psych effects)

πŸƒ CARD 5: Mixed Agonist-Antagonist Class Rules (Applies to Both)

Mnemonic: "CAWDS"
  • Ceiling effect for analgesia (and respiratory depression)
  • Avoid combining with full agonists (may precipitate withdrawal or ↓ analgesia)
  • Withdrawal precipitated in opioid-dependent patients
  • Dysphoria (especially pentazocine via Οƒ)
  • Safer respiratory profile than full agonists

πŸƒ CARD 6: Big Picture - The "Receptor Fingerprint" of Each Drug

Drug         ΞΌ(analgesia/RD)   ΞΊ(sedation/spinal)   Οƒ(dysphoria)
─────────────────────────────────────────────────────────────────
Morphine        +++                 +                   -
Fentanyl        ++++                -                   -
Pentazocine     antagonist         partial +            +++
Butorphanol     partial/antag      +++                  Β±

πŸƒ CARD 7: Clinical High-Yield One-Liners for Exam

  1. Dexmed > clonidine for Ξ±2 selectivity: 1600:1 vs 200:1 (7x difference)
  2. Only drug that causes arousable sedation = Dexmedetomidine
  3. Fentanyl = intraoperative opioid of choice; Morphine = postoperative/neuraxial
  4. M6G (active metabolite of morphine) accumulates in renal failure
  5. Pentazocine raises BP/HR/PAP - contraindicated in MI
  6. Butorphanol available intranasally; used in migraine/obstetrics
  7. Both Ξ±2 agonists: no significant respiratory depression - safe in respiratory compromised patients
  8. Wooden chest with high-dose fentanyl - treat with succinylcholine + intubation
  9. Clonidine withdrawal = rebound HTN + tachycardia; do NOT use Ξ²-blocker alone
  10. Context-sensitive half-life of fentanyl rises steeply with prolonged infusion (unlike remifentanil)

Sources: Barash's Clinical Anesthesia 9e (p.974-976, p.1553-1556); Morgan & Mikhail's Clinical Anesthesiology 7e (p.348-350); Lippincott Pharmacology (p.700-702)

Recent MI / IHD patient posted for strangulated hernia repair or emergency laparotomy β˜…β˜…β˜…β˜… anaesthetic management for mdanaesthesia exam .

Reading File
This is a complex clinical scenario. Let me run parallel searches across all key domains simultaneously.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have rich data from Miller's Anesthesia, Barash, and Sabiston. Let me compile the comprehensive answer now.

Recent MI / IHD Patient for Emergency Laparotomy / Strangulated Hernia Repair

β˜…β˜…β˜…β˜… Anaesthetic Management | MD Anaesthesia Exam


THE CORE CONFLICT

Emergency surgery CANNOT wait (strangulated hernia / peritonitis = life-threatening). Yet recent MI carries highest reinfarction / mortality risk perioperatively. Your job = minimize cardiac morbidity while safely conducting a life-saving procedure.

Mnemonic: "LIFE vs LIMB = LIFE wins β€” but protect the HEART"


πŸƒ CARD 1: Risk Stratification - Know BEFORE You Touch the Patient

Revised Cardiac Risk Index (RCRI) - 6 Predictors

Mnemonic: "I Have Chronic Heart Cerebro-vascular Disease"
#Risk FactorScore
1Intraperitoneal/intrathoracic/suprainguinal vascular surgery+1
2History of ischemic heart disease+1
3Congestive heart failure+1
4History of cerebrovascular disease+1
5Creatinine > 2 mg/dL+1
6Diabetes on insulin+1
  • Score 0 = 0.4% risk | Score 1 = 0.9% | Score 2 = 6.6% | Score β‰₯3 = >11% major cardiac event
Your patient: Emergency laparotomy (high-risk surgery) + IHD/recent MI = RCRI β‰₯ 2 minimum. HIGH RISK.

Key Timing Rule (ACC/AHA 2014):

  • Elective surgery: defer 60 days after recent MI
  • Emergency surgery: cannot defer - proceed with maximal precaution
  • Risk of 30-day postop MI/death is highest when surgery within 60 days of MI

πŸƒ CARD 2: Preoperative Assessment - "ABCDE" Framework

A - Airway
  • Full stomach (emergency, bowel obstruction) β†’ RSI mandatory
  • Assess for difficult airway (obesity, short neck, reduced mouth opening)
B - Breathing
  • Baseline SpOβ‚‚, CXR - look for pulmonary oedema/LVF
  • ABG if in distress
C - Cardiovascular (MOST CRITICAL)
  • Time since MI (hours/days/weeks?)
  • Current antiplatelet status (aspirin, clopidogrel, DAPT for stents)
  • Type of stent: BMS (bare metal stent) vs DES (drug-eluting stent)?
  • Recent ECG: ST changes, Q waves, arrhythmia
  • Echo/wall motion abnormality if available
  • LV function (EF?) - severe LV dysfunction = very high risk
  • Current medications (beta-blocker, statin, ACE inhibitor, nitrates)
  • BP, HR, capillary refill, signs of cardiogenic shock / decompensated HF
D - Drugs (Current medications)
  • Continue: beta-blockers, statins, nitrates, aspirin
  • Withhold/discuss: ACE inhibitors (may cause refractory hypotension), clopidogrel (bleeding risk vs stent thrombosis)
E - Electrolytes + Extremis
  • K⁺ (hypokalaemia worsens arrhythmia risk), Na⁺, creatinine
  • Level of haemodynamic compromise (is patient in shock?)

πŸƒ CARD 3: Goals of Anaesthetic Management

Mnemonic: "MODS = Maintain Oβ‚‚ Delivery, Stable Haemodynamics"

The cardinal rule in IHD:
Maintain balance between Myocardial Oβ‚‚ Supply and Demand
↑ Oβ‚‚ Demand (BAD)↓ Oβ‚‚ Supply (BAD)
Tachycardia (most dangerous)Hypotension
HypertensionAnaemia (Hb <8 g/dL in IHD)
Increased preload/afterloadHypoxia
Pain, light anaesthesia, shiveringCoronary vasospasm
Hypothermia (post-op)Tachycardia (↓ diastolic filling time)
Target parameters intraoperatively:
  • HR: 60-80 bpm (avoid tachycardia above all else)
  • MAP: 70-90 mmHg (keep within 20% of baseline)
  • SpOβ‚‚: β‰₯ 98%
  • Hb: β‰₯ 9-10 g/dL (in IHD, more generous transfusion threshold)
  • Temperature: normothermia (hypothermia β†’ catecholamine surge β†’ ischaemia)

πŸƒ CARD 4: Preoperative Preparation

Monitoring Setup (before induction):

  • 5-lead ECG with ST-segment analysis (II + V5 detect >95% ischaemia)
  • Pulse oximetry
  • Invasive arterial line (radial) - beat-to-beat BP, ABG access
  • Large-bore IV Γ— 2
  • Consider Central venous line - CVP, vasopressor access
  • Urinary catheter - hourly urine output

Drugs to have ready:

  • Vasopressors: Phenylephrine (pure Ξ± - raises BP without tachycardia), Noradrenaline, Metaraminol
  • Chronotropes: Atropine, Isoprenaline (for bradycardia)
  • Anti-ischaemics: IV Nitroglycerine (if ischaemia/HTN intraop)
  • Beta-blocker (IV): Esmolol/Metoprolol (short-acting for tachycardia)
  • Defibrillator/crash cart at bedside
  • Blood cross-matched and available

Pre-induction:

  • 100% Oβ‚‚ preoxygenation Γ— 3-5 min (desaturation during apnoea is catastrophic in IHD)
  • IV access, fluid status (but avoid overload - risks LV strain)
  • Continue beta-blocker if on it (abrupt cessation β†’ rebound tachycardia/ischaemia)
  • Consider IV fentanyl 1-2 ΞΌg/kg before induction (attenuates laryngoscopy response)

πŸƒ CARD 5: Induction of Anaesthesia

RSI is MANDATORY (full stomach - emergency surgery)

But RSI in IHD = "Haemodynamically Gentle RSI"

The problem with standard RSI:
  • Laryngoscopy/intubation β†’ massive sympathetic surge β†’ tachycardia + HTN β†’ ischaemia
  • Induction agents can cause hypotension β†’ coronary hypoperfusion

Induction Agents - Comparison:

AgentEffect on CVUse in IHD
Etomidate 0.3 mg/kgMinimal BP/HR changePREFERRED in haemodynamically compromised
Propofol 1.5-2 mg/kg↓↓ BP (vasodilation), minimal HR changeUse with care; reduce dose; titrate
Ketamine 1-2 mg/kg↑ HR, ↑ BP (sympathomimetic)AVOID in IHD (↑ Oβ‚‚ demand); use only if refractory shock
Thiopentone 3-5 mg/kg↓ BP, ↑ HR (reflex)Avoid if haemodynamically unstable
Recommended Induction Sequence for this patient:
  1. Preoxygenation 100% Oβ‚‚ Γ— 5 min
  2. IV fentanyl 2-3 ΞΌg/kg (blunts intubation response) - give 3-5 min before
  3. Lignocaine 1.5 mg/kg IV (blunts laryngoscopy pressor response)
  4. Etomidate 0.2-0.3 mg/kg OR titrated propofol + vasopressor ready
  5. Succinylcholine 1.5 mg/kg (RSI - no Sellick's/cricoid pressure used routinely now, controversial)
  6. Gentle, rapid laryngoscopy with best view - avoid prolonged attempts
  7. Confirm ET tube with capnography
Mnemonic for intubation adjuncts: "FLiS"
  • Fentanyl (opioid blunting)
  • Lignocaine (pressor response attenuation)
  • induction agent (etomidate preferred)
  • Succinylcholine RSI

πŸƒ CARD 6: Maintenance of Anaesthesia

Volatile vs TIVA:

Volatile (Sevoflurane/Isoflurane)TIVA (Propofol + Remifentanil)
Cardiac protectionYES - ischaemic preconditioningPropofol - no preconditioning
Coronary stealIsoflurane historically controversial (steal); sevoflurane saferNot applicable
HaemodynamicsDose-dependent ↓ BP; sevoflurane smoothPropofol ↓ BP; remifentanil ↓ HR
MACReduce with fentanyl/opioidsTitrate TCI
PreferredSevoflurane + fentanyl + Nβ‚‚O/Oβ‚‚ or air/Oβ‚‚Acceptable alternative
Ischaemic preconditioning with volatiles is a real, documented benefit - use sevoflurane.

Muscle Relaxation:

  • Atracurium (organ-independent metabolism) or Vecuronium (minimal CVS effects)
  • Avoid Pancuronium (tachycardia) and Gallamine in IHD

Opioids:

  • Fentanyl infusion intraoperatively (haemodynamically stable, no histamine)
  • Morphine postoperatively (PCA for pain control)
  • Avoid under-analgesia: pain β†’ catecholamine surge β†’ tachycardia β†’ ischaemia

Adjuncts:

  • Beta-blocker if tachycardia (esmolol 0.5 mg/kg bolus or infusion)
  • GTN (Nitroglycerine) infusion if ST elevation or hypertension (0.5-2 ΞΌg/kg/min)
  • Vasopressors if hypotension (phenylephrine preferred over ephedrine to avoid tachycardia)

πŸƒ CARD 7: Intraoperative Monitoring for Ischaemia

ECG - The 95% Rule:

  • Lead II = inferior ischaemia (RCA)
  • Lead V5 = anterior/lateral ischaemia (LAD)
  • II + V5 combined = detects >95% of ischaemic events
  • II + V4 + V5 = detects >99%

Signs of Intraoperative Ischaemia:

  • ST depression > 1 mm (subendocardial ischaemia - demand ↑)
  • ST elevation > 2 mm (transmural = plaque rupture / vasospasm)
  • New T-wave inversion
  • Sudden ↑ in LVEDP (PAC if used)
  • New wall motion abnormality on TOE

Treatment of Intraoperative Ischaemia:

  • Step 1: Correct cause (Tachycardia β†’ esmolol; Hypotension β†’ vasopressor/fluid; Hypertension β†’ deepen anaesthesia/GTN)
  • Step 2: IV GTN 0.5-2 ΞΌg/kg/min (vasodilates coronaries)
  • Step 3: Optimise Hb, oxygenation
  • Step 4: If ongoing - call cardiac team, consider post-op IABP / ICU

πŸƒ CARD 8: Special Considerations

Antiplatelet Management (Stent patients):

  • BMS placed < 4-6 weeks = defer elective surgery; continue aspirin if emergency
  • DES placed < 12 months = defer elective surgery; continue aspirin + clopidogrel in emergency (stent thrombosis > bleeding risk)
  • ACC/AHA: If surgery cannot wait, continue DAPT; consult cardiology
  • Heparin bridging may be considered

Stress Response:

  • Emergency laparotomy = maximal surgical stress
  • Catecholamine surge β†’ tachycardia, hypertension, platelet activation, hypercoagulability β†’ plaque rupture risk
  • Counter with: adequate depth of anaesthesia, fentanyl, beta-blockers, alpha-2 agonists (dexmedetomidine infusion)

Dexmedetomidine:

  • Ideal adjuvant in IHD: ↓ sympathetic tone, ↓ HR, ↓ catecholamines, no respiratory depression
  • Infusion 0.2-0.7 ΞΌg/kg/hr intraoperatively / ICU sedation

πŸƒ CARD 9: Regional Anaesthesia - Role?

Epidural Anaesthesia:

  • Thoracic epidural (T6-T10) for laparotomy - excellent analgesia, reduces surgical stress response
  • Benefits: ↓ sympathetic activation, ↓ pain, ↓ postop ileus, ↓ DVT
  • BUT in emergency: antiplatelet drugs β†’ epidural haematoma risk β†’ CONTRAINDICATED if on DAPT
  • Generally: not first choice for emergency in anticoagulated/antiplatelet patient

Conclusion for Route:

= General Anaesthesia (ETT + RSI) with IV fentanyl/sevoflurane + targeted monitoring

πŸƒ CARD 10: Postoperative Management

DomainAction
ICU admissionMandatory - high-risk patient, invasive monitoring
AnalgesiaMultimodal: IV morphine PCA + paracetamol + NSAIDs cautiously
MonitoringECG, troponin T at 6h, 12h, 24h postop
HaemodynamicsTarget HR 60-80, MAP 70-90, Hb β‰₯9
Beta-blockersResume immediately if pre-existing; start if new tachycardia
StatinsContinue (pleiotropic cardioprotection)
AntiplateletResume aspirin at 24-48hr if haemostasis achieved
TemperatureActive warming - normothermia mandatory (hypothermia β†’ shivering β†’ ↑Oβ‚‚ demand)
VentilationWean cautiously; avoid hypoxia/hypercarbia
Fluid balanceAvoid overload (LV dysfunction); CVP/UO guided
Troponin riseIf new rise: ECG, consult cardiology, consider anticoagulation

πŸƒ CARD 11: QUICK SUMMARY TABLE for Exam

PhaseKey Point
Pre-opRCRI score, time since MI, stent type, current medications, LV function
MonitoringArterial line, II+V5 ECG, SpOβ‚‚, +/- CVP; crash cart ready
InductionRSI + etomidate + fentanyl + lignocaine; gentle laryngoscopy
MaintenanceSevoflurane (ischaemic preconditioning) + fentanyl; target HR 60-80, MAP 70-90
Ischaemia rxEsmolol (tachycardia), GTN (ST rise/HTN), vasopressor (hypotension)
AvoidTachycardia, hypotension, hypothermia, hypoxia, hypovolaemia, ketamine
Post-opICU, troponin serial, resume beta-blocker + statin, normothermia

πŸƒ CARD 12: One-Liners the Examiner Wants to Hear

  1. "Emergency surgery cannot be deferred despite MI; our goal is to minimise perioperative cardiac morbidity."
  2. "RSI is mandatory due to full stomach, but we use a haemodynamically gentle technique."
  3. "Etomidate is the induction agent of choice in haemodynamically compromised patients."
  4. "Sevoflurane offers ischaemic preconditioning - this is a real biological benefit in IHD."
  5. "Tachycardia is the most dangerous haemodynamic perturbation in IHD."
  6. "II + V5 ECG leads detect > 95% of perioperative ischaemia."
  7. "Beta-blockers must be continued; abrupt cessation causes rebound tachycardia and ischaemia."
  8. "In DES stent < 12 months: continue DAPT for emergency surgery - stent thrombosis kills faster than bleeding."
  9. "Phenylephrine preferred over ephedrine for hypotension - it raises BP without tachycardia."
  10. "Post-op ICU, serial troponins, normothermia, and immediate resumption of cardiac medications are non-negotiable."

Sources: Miller's Anesthesia 10e (p.3874-3877, p.7919); Sabiston Textbook of Surgery 11e (p.448-450); Barash's Clinical Anesthesia 9e; ACC/AHA 2014 Guidelines on Perioperative Cardiovascular Evaluation
This is a shared conversation. Sign in to Orris to start your own chat.